Genistein inhibited the proliferation of kidney cancer cells via CDKN2a hypomethylation: role of abnormal apoptosis

CA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue

(2019) Huai-Lu Ma et al.   BIOMEDICINE & PHARMACOTHERAPY

Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma

(2018) Fatima Ardito et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

The Role of DNA Methylation in Renal Cell Carcinoma

(2018) Brittany N. Lasseigne et al.   Molecular Diagnosis & Therapy

Genistein Promotes Proliferation of Human Cervical Cancer Cells Through Estrogen Receptor-Mediated PI3K/Akt-NF-κB Pathway

(2018) Hai-Hong Chen et al.   Journal of Cancer

Dual effects of isoflavonoids from Pueraria lobata roots on estrogenic activity and anti-proliferation of MCF-7 human breast carcinoma cells

(2018) Soo-Yeon Ahn et al.   BIOORGANIC CHEMISTRY

Genistein attenuates isoflurane-induced neurotoxicity and improves impaired spatial learning and memory by regulating cAMP/CREB and BDNF-TrkB-PI3K/Akt signaling

(2017) Tao Jiang et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

DNA Methylation Machinery in the Endometrium and Endometrial Cancer

(2016) VERONIKA CAPLAKOVA et al.   ANTICANCER RESEARCH

Zinc enhances CDKN2A , pRb1 expression and regulates functional apoptosis via upregulation of p53 and p21 expression in human breast cancer MCF-7 cell

(2016) Nada Al-saran et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases

(2015) Tianhong Pan et al.   CANCER LETTERS

Genistein and Cancer: Current Status, Challenges, and Future Directions

(2015) Carmela Spagnuolo et al.   Advances in Nutrition

Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines

(2014) Kwai Fung Hui et al.   BRITISH JOURNAL OF HAEMATOLOGY

Promoter hypermethylation ofCDKN2A,MGMT,MLH1, andDAPKgenes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients

(2013) Stefano Pierini et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer

(2013) Kit W. Tam et al.   Journal of Thoracic Oncology

Protective Effect of Fermented Soybean Dried Extracts against TPA-Induced Oxidative Stress in Hairless Mice Skin

(2013) Sandra R. Georgetti et al.   Biomed Research International

Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma

(2013) Christopher J Ricketts et al.   Clinical Epigenetics

The significance of epigenetic alterations in lung carcinogenesis

(2012) Ewa Brzeziańska et al.   MOLECULAR BIOLOGY REPORTS

Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma

(2010) Antal Csepregi et al.   BMC CANCER

DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables

(2010) Sitharthan Kamalakaran et al.   Molecular Oncology

Genetic Determinants of Cutaneous Melanoma Predisposition

(2010) Durga Udayakumar et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Genome-wide DNA methylation profiles in precancerous conditions and cancers

(2009) Yae Kanai   CANCER SCIENCE

Frequent Deletion and Methylation in SH3GL2 and CDKN2A Loci are Associated with Early- and Late-onset Breast Carcinoma

(2008) Satyabrata Sinha et al.   ANNALS OF SURGICAL ONCOLOGY

Frequent p16-Independent Inactivation of p14ARF in Human Melanoma

(2008) Daniel E. Freedberg et al.   JNCI-Journal of the National Cancer Institute